ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

Search

Biotage AB

Uždarymo kaina

141.9 0.35

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

141.4

Max

142.1

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-154M

4M

Pardavimai

-197M

385M

P/E

Sektoriaus vid.

44.606

24.598

Pelnas, tenkantis vienai akcijai

0.325

Dividendų pajamingumas

1.16

Pelno marža

1.039

Darbuotojai

622

EBITDA

-194M

28M

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.16%

4.30%

Kitas uždarbis

2025-07-16

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

4.1B

11B

Ankstesnė atidarymo kaina

141.55

Ankstesnė uždarymo kaina

141.9

Biotage AB Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-04-22 06:50; UTC

Įsigijimai, susijungimai, perėmimai

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

2025-04-22 06:04; UTC

Įsigijimai, susijungimai, perėmimai

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

2025-04-22 06:03; UTC

Įsigijimai, susijungimai, perėmimai

KKR: Biotage Board Recommends Shareholders Accept Offer

2025-04-22 06:02; UTC

Įsigijimai, susijungimai, perėmimai

KKR: Offer Values Biotage at SEK11.61B

2025-04-22 06:02; UTC

Įsigijimai, susijungimai, perėmimai

KKR Makes SEK145 a Share Bid For Biotage

Akcijų palyginimas

Kainos pokytis

Biotage AB Prognozė

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.